|
21
|
158
|
5t43A |
Nmr structure of apo-form human tear lipocalin |
|
47
|
174
|
5nu8A |
Structure of human urine rbp4 saturated with palmitate |
|
40
|
159
|
5nukA |
Engineered beta-lactoglobulin: variant i56f-l39a-m107f in complex with chlorpromazine (lg-faf-clp) |
|
45
|
174
|
5nuaA |
Structure of human urine rbp4 saturated with laurate |
|
47
|
174
|
5nu9A |
Structure of human amniotic fluid rbp4 saturated with palmitate |
|
44
|
174
|
5nu7A |
Structure of human holo plasma rbp4 |
|
41
|
161
|
5numA |
Engineered beta-lactoglobulin: variant f105l-l39a in complex with chlorpromazine (lg-la-clp) |
|
40
|
161
|
5nunA |
Engineered beta-lactoglobulin: variant f105l-l39a-m107f in complex with chlorpromazine (lg-laf-clp) |
|
47
|
174
|
5nu6A |
Structure of non-fluorescent human amniotic fluid rbp4 |
|
48
|
174
|
5nubA |
Structure of human amniotic fluid rbp4 saturated with laurate |
|
47
|
174
|
5nu2A |
Structure of non-fluorescent human urine rbp4 |
|
45
|
174
|
5ntyA |
Structure of non-fluorescent human plasma rbp4 |
|
38
|
160
|
5nujA |
Engineered beta-lactoglobulin: variant i56f-l39a in complex with chlorpromazine (lg-fa-clp) |
|
31
|
133
|
5n4qA |
Human myelin protein p2, mutant t51p |
|
39
|
172
|
5nknA |
Crystal structure of an anticalin-colchicine complex |
|
28
|
133
|
5n4mA |
Human myelin protein p2, mutant i43n |
|
34
|
134
|
5ljgA |
Crystal structure of holo human crbp1 |
|
31
|
162
|
5lkfA |
Bovine beta-lactoglobulin complex with myristic acid at high pressure (0.55 gpa) |
|
33
|
134
|
5ljdA |
Crystal structure of holo human crbp1/k40l mutant |
|
29
|
133
|
4zh9A |
Crystal structure of the domain-swapped dimer wild-type of human cellular retinol binding protein ii |
|
28
|
132
|
5bvsA |
Linoleate-bound pfabp4 |
|
31
|
133
|
4zh6A |
Crystal structure of the domain-swapped dimer y60l mutant of human cellular retinol binding protein ii |
|
28
|
132
|
5bvqA |
Ligand-unbound pfabp4 |
|
33
|
139
|
5hzqA |
Crystal structure of cellular retinoic acid binding protein 2 (crabp2)-aryl fluorosulfate covalent conjugate |
|
33
|
132
|
5b27A |
The 1.02a structure of human fabp3 m20s mutant complexed with palmitic acid |
|
39
|
139
|
5h9aA |
Crystal structure of the apo form of human cellular retinol binding protein 1 |
|
39
|
139
|
5hbsA |
Crystal structure of human cellular retinol binding protein 1 in complex with all-trans-retinol at 0.89 angstrom. |
|
31
|
132
|
5b28A |
The 0.90a structure of human fabp3 f16v mutant complexed with palmitic acid |
|
35
|
139
|
5h8tA |
Crystal structure of human cellular retinol binding protein 1 in complex with all-trans-retinol |
|
38
|
140
|
5ha1A |
Crystal structure of human cellular retinol binding protein 1 in complex with retinylamine |
|
36
|
157
|
5hteA |
Recombinant bovine beta-lactoglobulin variant l1a/i2s (sblgb#2) |
|
30
|
128
|
5gkbA |
Crystal structure of fatty acid-binding protein in brain tissue of drosophila melanogaster without citrate inside |
|
27
|
133
|
4zcbA |
Human crbpii mutant - y60w dimer |
|
26
|
129
|
5ggeA |
Fatty acid-binding protein in brain tissue of drosophila melanogaster |
|
37
|
133
|
5fazA |
Crystal structure of the q108k:k40l:t51v mutant of human cellular retinol binding protein ii in complex with all-trans-retinal after 24 hours of incubation at 1.4 angstrom resolution |
|
33
|
133
|
5f7gA |
Crystal structure of the q108k:k40l:t51v:r58y:y19w:q38l mutant of human cellular retinol binding protein ii in complex with all-trans-retinal at 1.48 angstrom resolution |
|
35
|
133
|
5f6bA |
Crystal structure of the q108k:k40l:t51v:r58y:y19w mutant of human cellular retinol binding protein ii in complex with all-trans-retinal at 1.3 angstrom resolution |
|
39
|
133
|
5f58A |
Crystal structure of the q108k:k40l:t51v:r58f mutant of human cellular retinol binding protein ii in complex with all-trans-retinal after 24 hours of incubation at 1.54 angstrom resolution |
|
36
|
133
|
5ffhA |
Crystal structure of the q108k:k40l:t51v:r58w:y19w mutant of human cellular retinol binding protein ii in complex with all-trans-retinal at 1.68 angstrom resolution |
|
41
|
162
|
5eeeA |
Bovine lactoglobulin complex with decanol |
|
31
|
134
|
5edbA |
Human fatty acid binding protein 4 in complex with 6-chloro-2-methyl-4-phenyl-quinoline-3-carboxylic acid at 1.18a |
|
36
|
162
|
5eedA |
Ovine lactoglobulin complex with decanol |
|
34
|
133
|
5edcA |
Human fabp4 in complex with 6-chloro-4-phenyl-2-piperidin-1-yl-quinoline-3-carboxylic acid at 1.29a |
|
28
|
133
|
4zr2A |
Crystal structure of the domain-swapped dimer k40l:q108k:y60w mutant of human cellular retinol binding protein ii |
|
28
|
133
|
5dpqA |
Crystal structure of e72a mutant of domain swapped dimer human cellular retinol binding protein |
|
35
|
133
|
5dg4A |
Crystal structure of monomer human cellular retinol binding protein ii-y60l |
|
32
|
135
|
5d47A |
Crystal structure of fabp4 in complex with 3-[5-cyclopropyl-3-(3-methoxypyridin-4-yl)-2-phenyl-1h-indol-1-yl] propanoic acid |
|
28
|
133
|
5d8jA |
Development of a therapeutic monoclonal antibody targeting secreted ap2 to treat type 2 diabetes. |
|
34
|
136
|
5d4aA |
Crystal structure of fabp4 in complex with 3-(2-phenyl-1h-indol-1-yl)propanoic acid |
|
30
|
136
|
5d48A |
Crystal structure of fabp4 in complex with 3-{5-cyclopropyl-3-(3,5-dimethyl-1h-pyrazol-4-yl)-2-[3-(propan-2-yloxy) phenyl]-1h-indol-1-yl}propanoic acid |
